Estimation of Vitamin D level and Its relation to Glycemic control in Type 2 Diabetes Mellitus by Arun, S
ESTIMATION OF VITAMIN D LEVEL AND ITS RELATION TO 
GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS 
 
 
Dissertation submitted to 
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY 
CHENNAI - 600 032 
 
 
 
In partial fulfillment of the regulations 
for the award of the degree of 
M.D. DEGREE BRANCH - I 
GENERAL MEDICINE 
 
 
GOVERNMENT MOHAN KUMARAMANGALAM 
MEDICAL COLLEGE, SALEM 
APRIL 2013 
CERTIFICATE 
This is to certify that the dissertation entitled “Estimation of Vitamin D 
level and its relation to glycemic control in type 2 Diabetes Mellitus” 
is a bonafide work done by  Dr.S.Arun in M.D BRANCH I GENERAL 
MEDICINE to be submitted to The Tamil Nadu Dr.M.G.R Medical 
University, in fulfilment of the University Rules and Regulation for the 
award of M.D. Degree Branch I General Medicine, under my supervision 
and guidance, during the academic period from October 2010 to 
September 2012. 
 
 
 
Guide 
Prof. Dr. S.R. SUBRAMANIAN, 
                                     M.D. DCH., 
Associate Professor of Medicine, 
Govt. Mohan Kumaramangalam 
Medical College ,Salem 
Co-ordinator 
Prof. Dr. R. ANBALAGAN, M.D., 
Professor & HOD of General Medicine, 
Govt. Mohan Kumaramangalam 
Medical College ,Salem 
  
Prof. Dr. R. VALLINAYAGAM, M.D., 
Dean, 
Govt. Mohan Kumaramangalam 
Medical College, 
Salem 
DECLARATION 
I solemnly declare that this dissertation “Estimation of Vitamin D 
level and its relation to glycemic control in type 2 Diabetes Mellitus” 
was prepared by me at Government Mohan Kumaramangalam Medical 
College and Hospital, Salem-636030 under the guidance and supervision 
of  Prof. DR.R. ANBALAGAN, M.D., HOD of Medicine, Govt. Mohan 
Kumaramangalam Medical College and Hospital Salem. 
This dissertation is submitted to The Tamil Nadu Dr. M.G.R. 
Medical University, Chennai in fulfillment of the University regulations 
for the award of the degree of M.D. Branch I General Medicine. 
 
Place : Salem 
Date :                                                                                 
       (Dr. ARUN.S)                          
 
                                                       
  
ACKNOWLEDGEMENT 
I am extremely thankful to DR. R.VALLINAYAGAM, M.D., 
Dean , Govt. Mohan Kumaramangalam Medical College Salem, for 
allowing me to utilize the hospital facilities for doing this work. 
I express my deep sense of gratitude and indebtedness to  
Prof. Dr. R. ANBALAGAN, M.D., Professor & Head of the Department 
of Medicine, for giving me inspiration, valuable guidance and help in 
preparing this dissertation. 
I express my deep sense of gratitude and heartfelt thanks to my 
esteemed Guide Prof. DR. S.R.SUBRAMANIAN, M.D. DCH, for his 
support and advice throughout the study . 
I thank all medical unit chiefs Prof. DR.A.THANGARAJU, M.D., 
Prof. DR. S. RAMASAMY M.D., Prof. DR. V. SUNDARAVEL M.D., 
Prof. DR. R. MANOHARI M.D., for their advices and kind helps. 
My sincere thanks to DR. A. RAVI, M.D., and  
DR. J.THIYAGARAJAN M.D., Assistant professors in department of 
medicine for guiding me in the technical and clinical aspects during 
each and every step of this study. 
And finally with great happiness, I thank all patients for their 
sincere co-operation extended to me during this study. 
My sincere thanks to M/s. AMAZE COMPUTERS and  
Mrs. JAYANTHI statistician for the neat execution of this dissertation. 
 
                                                  
  
Your digital receipt
This receipt acknowledges that Turnitin received your paper. Below you will find the receipt information
regarding your submission.
Paper ID 292618578
Paper title Estimation of vitamin D level & its relation to glycemic control in type 2diabetes mellitus
Assignment
title Medical
Author Arun 20101351 M.D. General Medicine
E-mail arun_scoobi@yahoo.co.in
Submission
time 27-Dec-2012 12:16AM
Total words 5652
First 100 words of your submission
INTRODUCTION Diabetes is a killer disease and a disease of development. Changes in lifestyle and
urbanisation combine together to increase a individual’s risk for diabetes substantially. In developing
countries in particular young people are hit by this epidemic causing significant morbidity and mortality
early in their lives. Working people are particularly affected which causes a serious risk to the
economical development of these countries. As these people start to live longer and these countries
develop this epidemic will only rise alarmingly unless effective treatment and preventive measures are
put in place (1). Vitamin D the so called ‘Sunshine Vitamin’ is creating interest in the...
Copyright 2012 Turnitin. All rights reserved.
 
CONTENTS 
S. No. Particulars Page No. 
1. INTRODUCTION 1 
2. AIM OF STUDY  4 
3. LITERATURE REVIEW 5 
4. MATERIALS AND METHODS 54 
5. RESULTS  56 
6. DISCUSSION 72 
7. CONCLUSION 75 
8. ABBREVIATIONS  
9. PROFORMA  
10. BIBLIOGRAPHY   
11. MASTER CHART                                           
 
1 
 
INTRODUCTION 
Diabetes is a killer disease and a disease of development. Changes 
in lifestyle and urbanisation combine together to increase a individual’s 
risk for diabetes substantially. In developing countries in particular young 
people are hit by this epidemic causing significant morbidity and 
mortality early in their lives. Working people are particularly affected 
which causes a serious risk to the economical development of these 
countries. As these people start to live longer and these countries develop 
this epidemic will only rise alarmingly unless effective treatment and 
preventive measures are put in place (1). 
Vitamin D the so called ‘Sunshine Vitamin’ is creating interest in 
the last decade because it has been researched to be associated with a 
multiple number of diseases like hypertension, heart disease, diabetes , 
cancer and so on (2). Research and various interventional studies done on 
vitamin D uniformly stated that this vitamin is a definite superstar when it 
comes to maintaining health. The following diseases have been 
extensively studied and found to be associated with vitamin D deficiency: 
Hypertension , Obesity, Dyslipidemia , Type 1 and type 2 diabetes 
mellitus, Coronary artery heart disease, Stroke, Pulmonary tuberculosis, 
Osteoporosis, Cancer, Rheumatoid arthritis, Multiple sclerosis, 
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Alzheimer’s disease, Depression, Infections, Seasonal affective disorder 
and overall morbidity and mortality (3). 
There is plenty of evidence stating that vitamin D deficiency could 
well be contributed to the pathogenesis of both types of diabetes (type 1 
& 2). The beta cells in the pancreas that is responsible for insulin 
secretion contains alpha 1 hydroxylase enzyme and vitamin D receptors 
(VDR’s) (4). It has been shown through various interventional studies 
that vitamin D supplementation improves insulin resistance and glucose 
tolerance (5) (6).  Vitamin D deficiency directly leads to reduced insulin 
secretion. Indirectly probably by altering the calcium flux through beta 
cell membranes, it diminish the calcium’s ability to influence insulin 
secretion. In peripheral tissues it enhances insulin action by increasing the 
expression of insulin receptors, enhances insulin’s response to glucose 
transport, and improving systemic inflammation by decreasing the effects 
of various cytokines (7). 
Studies from all corners of India have universally shown a high 
prevalence of vitamin D deficiency in our country despite being in the 
tropical zone. All age groups have been reported to be vitamin D 
deficient and so are the urban and rural population (8). 
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Hypertension and diabetes tops the list of fastest growing non 
communicable diseases worldwide. Currently the prevalence of diabetes 
in India is very high and if this trend prevails by the year 2030, Indians 
would be taking the highest toll of the disease worldwide. The reason for 
glycemic control getting worsened in the winter months is believed to be 
due to the simultaneous fall of active vitamin D in these seasons (9). 
Vitamin D3 is inexpensive and readily available. Hence supplementation 
with the same will help us achieve adequate glycemic control and thereby 
preventing the dreadful diabetic complications in future. Also the most 
common associated problems with diabetes like hypertension, 
cardiovascular diseases, infections can be far lessened. 
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AIM OF THE STUDY 
1) The aim of my present study is to estimate vitamin D levels in 
patients with type 2 Diabetes and to find out its relation to 
glycemic control, as assessed by HbA1c percentage. 
2) Insulin sensitivity improves with repletion of vitamin D stores as 
shown in various studies. In my study patient having low vitamin 
D level and poor glycemic control will be advised vitamin D 
supplementation accordingly. 
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LITERATURE REVIEW 
Diabetes mellitus is a disease of modern life. It refers to a group of 
metabolic disorders in man characterized by high blood sugar levels and 
loss of glucose in the urine. It results from defects in insulin secretion, 
insulin action or a combination of both. Lack of insulin whether absolute 
or relative affects the metabolism of carbohydrates, proteins, fats, 
electrolytes and water with consequences that might be grave. The 
chronic hyperglycemia associated with this condition causes damage and 
dysfunction of various organs (kidneys, eyes, nerves, heart and blood 
vessels) thereby creating widespread morbidity and mortality. 
Although a number of specific causes for diabetes mellitus have 
been identified the etiology and pathogenesis of various forms are far less 
poorly understood.  Most cases of diabetes falls into 2 main pathogenetic 
categories namely type 1 and type 2 diabetes mellitus (10) . The 
following image depicts the clinical stages and etiologic types of diabetes 
which reflects that diabetes progresses through several stages in its 
natural history and that individual subjects may move from one stage to 
another in either direction.  
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90% of  cases of diabetes account for type 2 diabetes and is 
frequently associated with clinical obesity. 
 
The metabolic derangements associated with diabetes largely 
reflect the magnitude of the deficiency in insulin concentration and/or 
insulin action present. Mild deficiency leads to an impairment in the 
capacity to effectively increase the storage of ingested fuels (eg. 
Postprandial hyperglycemia) whereas in severe deficiency various 
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catabolic processess including lipolysis, gluconeogenesis, ketogenesis 
and proteolysis occurs. 
GLOBAL BURDEN : 
The number of adults living with diabetes is estimated to be around 
366 million people representing 8.3% of global adult population. If this 
trend prevails the present number will increase to 552 million people or 
9.9% of adult population which approximately equals to 3 more people 
developing diabetes every 10 seconds (11).  
The following statistics are put forward by the International 
Diabetes Federation (IDF) in their 2012 update (12) : 
1) 366 million people have diabetes in 2011, by 2030 this number 
will increase to 552 million. 
2) 80% of people having diabetes live in developing countries. 
3) The grunt of the disease are taken by people between 40-59 
years of age. 
4) The prevalence of type 2 diabetes is increasing in every country. 
5) 183 million people ( 50% ) are undiagnosed with diabetes. 
6) In 2011, 4.6 million deaths occurred related to diabetes. 
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7) Incidence of type 1 diabetes is also increasing with 78,000 
people developing it every year. 
8) Diabetes caused huge economical burden in healthcare 
expenditures constituting 11% of total health expenditures in 
adults. 
 
 
(Images from IDF Diabetes atlas fifth edition 2012 Update) 
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Diabetes at a glance, 2012  South-East Asia (SEA) (13) : 
Larger than 70.3 million people in the South east asia Region have 
diabetes; by 2030 this number will probably rise to 120.9 million. 
1)  8.7 % adults in SEA Region have diabetes.  
2)  One fifth of all adult diabetic patients, live in this region . 
3) 1.1 million deaths has been caused by diabetes in the  SEA 
region this year.  
4)  USD 4.6 billion were spent on treating diabetes in the region.  
               
10 
 
Over 30 million people in India has been diagnosed with diabetes. 
The crude prevalence rate in urban areas of India is about 9%. In rural 
areas the prevalence is approximately 3% of the total population. Various 
studies in India have shown that Indian diabetic subjects have very poor 
glycemic control ( HbA1c > 8%). Diabetes is also beginning to appear 
much earlier in life in India. Also the closely associated problems like 
Hypertension, Dyslipidemia, Obesity, Coronary artery heart disease and 
Peripheral vascular disease are in very percentage (14) (15). Overall the 
management of diabetes and care in India is overwhelming and leaves 
much less to be desired. Increased awareness among health care 
professionals to improve the standards of diabetes care in India is the 
need of the hour. 
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VITAMIN D – ‘THE SUNSHINE VITAMIN’ : 
Vitamin D is a fat soluble steroid vitamin with multitude of 
functions in the body.  In nature only a few foods contain vitamin D such 
as fatty fish, liver and egg yokes (16). However most foods are fortified 
with vitamin D most commonly milk and breakfast cereal. Most of the vit 
D formed in the body is due to the result of sun exposure on the skin. 
 
      An adult in a bathing suit exposed to one minimal erythemal 
dose of ultraviolet radiation ( a slight pinkness of the skin after exposure) 
is equivalent to ingesting 10,000 – 25000 IU of vitamin D. A variety of 
factors limit the skin’s production of vitamin D3 like aging, use of 
sunscreens and increased skin pigmentation. 
12 
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Suggested dietary sources are listed below (17): 
 
There are five forms of vitamin D ( Vit D1, D2, D3, D4, D5) of 
which vitamin D2 and D3 are the major forms in human beings. They are 
collectively called as ‘calciferol’(18). 
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produce vitamin D is blocked by the earth’s atmosphere when the sun did 
not rise to over 35° above the horizon (20). Thus synthesis of vitamin D 
will be poor in the two extremes of the day (morning & evening) , in the 
winter months and more so in areas of higher latitude(21) (22).                      
 
 After vitamin D3 is produced whether in the skin or consumed in 
the food , it enters the circulation and metabolised in the liver by 25 
hydroxylase (23) to 25 Hydroxy vitamin D (25(OH)D) which is the major 
circulating and storage form of vitamin D. 25(OH)D is then converted to 
1,25 Dihydoxy vitamin D (1,25 (OH)2D) , the active hormonal form of 
vitamin by the enzyme 1,25 alpha hydroxylase (24) in the kidney. The 
active vitamin is then transferred to the target tissues after binding to 
vitamin D binding protein (DBP) (25). 
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MOLECULAR ACTIONS OF VITAMIN D : 
At the cellular level there are two types of responses to 1,25(OH)2 
D : the rapid response which occurs within seconds to minutes and the 
genomic response which occurs from minutes to days (26). In the rapid 
response the active vitamin D binds to either vitamin D receptor (VDR) 
17 
 
or the vitamin D membrane associated rapid response steroid binding 
protein (MARRS) in the plasma membrane. This activates the G protein 
that causes increased intracellular cyclic AMP which increases the 
activity of protein kinase C and mitogen activated protein kinase leading 
to biologic responses (27). During the genomic response the 1,25(OH)2D 
binds to nuclear VDR and dimerizes with retinoic X receptor (RXR) 
forming a heterodimer which binds to vitamin D responsive elements 
(VDRE) modulating tissue specific gene expressions and protein 
synthesis (28) (29). Ultimately this genomic effect will lead to 
physiological responses. 
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BIOLOGIC FUNCTIONS OF VITAMIN D: 
1) The primary function of vitamin D  is to promote the absorption of 
calcium in the intestine and therby maintaining adequate serum 
calcium (Ca2+) and phosphate (Po4 2-) concentrations. This enables 
normal mineralization of bone. It is also required for bone growth 
and remodelling by osteoblasts & osteoclasts (30). 
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2) Despite normal serum calcium levels the parathyroid gland has a 
tendency to hyperproliferate if vitamin D is deficient. Thus 
Vitamin D helps to suppress the parathyroids by a negative 
feedback mechanism, which is a essential part in the treatment of 
renal osteodystrophy (31). 
3) Vitamin D may enhance immune system function and reduce the 
risk of autoimmunity, a condition in which the body attacks itself 
by production of various auto antibodies. It decreases the 
expression of various cytokines thereby reducing systemic 
inflammation. Chronic inflammation causes blood vessel damage 
and dyslipidemia and can increase the risk of developing heart 
disease. By this function vit D gives protection against various auto 
immune disease and coronary artery heart disease. 
4) Vit D plays a role in insulin secretion in pancreatic beta cells and 
improves insulin sensitivity in peripheral tissues. Thus plays a 
crucial role in the pathogenesis of both type 1 and type 2 diabetes 
mellitus. 
5) Prevention of cancer especially prostate, colon and breast 
cancer(32). 
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6) Neuroprotection (33). 
7) Prevention of infections especially pulmonary tuberculosis, and 
prevention of exacerbation in asthmatics.(34). 
8) Vitamin D has various renal protective effects. They include 
attenuation of the development of glomerulosclerosis and retarding 
the progression of albuminuria thereby preventing progression to 
chronic kidney disease (35). 
9) Alteration in vit D status causes increased propensity to become 
obese by upregulating insig 2 (insulin induced gene 2) gene 
expression in the adipose tissue that causes fat mass 
accumulation(36). 
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Vitamin D Deficiency: 
The symptoms of vitamin D deficiency are those of calcium 
deficiency. The bones fail to calcify normally and may grow so weak that 
it cannot support the weight of the body developing the characteristic 
bow legs, the most obvious sign of the disease in children with ‘Rickets’. 
The adult form of rickets is called ‘Osteomalacia’. 
Inadequate vitamin D is a recognised risk factor for Osteoporosis 
(reduced mineral density). Without vitamin D, the absorption of calcium 
is limited and bone remodelling is impaired. This combination leads to a 
loss of bone mass. 
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Changing face of Vitamin D : 
Over the past decade it was realised that vitamin D deficiency is no 
longer just about bones. After the understanding that vitamin D receptors 
has been extensively distributed in various tissues of the body like skin 
keratinocytes, almost all cells regulating immune system, pancreatic islet 
cells, enterocytes, proximal renal tubular cells, cancer cells such as colon, 
breast, prostate and lung, hair follicular cells, testis, prostate, ovaries, 
granulomatous tissue in sarcoidosis, smmoth muscles, the face of vitamin 
D has changed. Soon various autoimmune diseases and many cancers has 
been studied and found to be associated with vitamin D deficiency. 
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The following diseases has been linked to vitamin D deficiency (37): 
• Osteoporosis / osteomalacia 
• Coronary artery heart disease 
• Stroke 
• Hypertension 
• Arteriosclerosis  
• Cancer especially prostate, breast, colon, lung and non 
Hodgkin’s  lymphoma 
• Chronic muscle, bone and joint pain 
• Dental caries,  
• Periodontal disease. 
• Metabolic syndrome. 
• Type 1 and type 2 diabetes mellitus 
• Obesity 
• Inflammatory bowel diseases 
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• Rheumatoid arthritis 
• Sjogren’s syndrome. 
• Various autoimmune diseases ( multiple sclerosis) 
• Pulmonary tuberculosis 
• Epilepsy 
• Alzheimers disease 
• Parkinson’s disease. 
• Schizophrenia ,  
• Depression and mood disorders 
• Chronic fatigue syndrome. 
• Autism  
• Attention deficit hyperactivity disorder (ADHD). 
• Infertility  
• Bronchial asthma and upper respiratory tract infections. 
• Preeclampsia  
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• Congestive heart failure 
• Peripheral vascular disease. 
• Premature greying of hair. 
• Osteoarthritis. 
• Fibromyalgia  
• Muscle myopathy and increased falls. 
• Psoriasis. 
• Congenital birth defects. 
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The following image shows the role of vitamin D as an adjunct to 
Anti tuberculous therapy (ATT) in pulmonary tuberculosis. 
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VITAMIN D AND DIABETES MELLITUS: 
Vitamin D deficiency has shown to be associated with both type 1 
and type 2 diabetes mellitus. 
Vit D and Type 1 diabetes mellitus :  
Autoimmune destruction of pancreatic beta cells is the 
pathogenetic mechanism causing type 1 diabetes. Almost all cells 
regulating the immune system contain Vitamin D receptors (VDR) (38).  
1.  Vitamin D inhibits dendritic cell maturation, repress type 1 
cytokines, and upregulate regulatory T cells (39). 
2. Vitamin D  also suppresses the antigen presenting capacity of 
macrophages, modulates CD4 Lymphocyte development and 
inhibit the production of interferon c and interleukin2. These 
cytokines have a role in activating macrophages and cytotoxic T 
Lymphocytes  which in turn lead to beta cell destruction that 
secretes insulin. 
3. Thus by its immunomodulatory action (40) vitamin D plays a role 
in the pathogenesis of type 1 diabetes. 
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In recent onset type 1 DM, administration of 0.25 µg calcitriol on 
alternate days for 1 year has been shown to have a modest effect on 
residual pancreatic beta cell function after 6 months suggesting a 
potential role in treatment after diagnosis. 
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VITAMIN D AND TYPE 2 DIABETES : 
The pathogenesis of type 2 diabetes involves both beta cell 
dysfunction and insulin resistance. However insulin resistance is the 
major culprit which is defined as the common pathologic state in which 
target cells ( muscle, liver and adipose tissue ) fails to respond to normal 
levels of circulating insulin (41).  
The following are the mechanisms by which vitamin D deficiency 
has been linked to insulin resistance and type 2 diabetes: 
 Optimal concentrations of intracellular calcium ( 140-370nm) is 
needed for insulin to mediate its effect on target tissues. Vitamin D 
deficiency leads to elevated parathyroid hormone levels (PTH). 
This hyperparathyroidism cause a paradoxical rise in intracellular 
calcium level ( ‘calcium paradox’ ) more than the optimal level that 
results in diminished cellular response to insulin (42). 
 Vitamin D regulates the transcription & expression of insulin 
receptors in peripheral tissues thereby enhancing insulin 
responsiveness for glucose transport (43). 
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 Vitamin D decreases the expression of various inflammatory 
cytokines thereby keeping systemic inflammation in check (44). 
 The mechanism of insulin secretion in beta cells is critically 
dependent on changes in intracellular calcium concentration. 
Vitamin D regulates extracellular calcium levels and calcium flux 
through beta cell membranes. Either vitamin D or calcium 
deficiency alter the physiological balance between intracellular and 
extracellular calcium in beta cells interfering with insulin synthesis 
and secretion (45). 
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HUMAN STUDIES LINKING VITAMIN  D AND DIABETES : 
   
• The NHANES ( National Health And Nutrition Examination Survey) 
Group (46) : 
Study period : 2003-2006. Evaluated 9,773 U.S. adults > 18 years. 
RESULT :   Study showed a mechanistic link between serum 
vitamin D levels, glucose homeostasis and the evolution of 
diabetes. 
• Kositsawat et al : (47) 
RESULT : Based on their own study concluded that patients with 
elevated A1C levels should be evaluated for vitamin D 
insufficiency (47). 
• Kayaniyil et al : (49) 
 - A linear regression analysis of 712 subjects after evaluating   
serum 25(OH)D levels and assessing insulin sensitivity by means 
of the homeostaSis model of insulin resistance. 
RESULTS : Vitamin D was significantly correlated to insulin 
resistance and beta cell function in their multiethnic sample. 
Concluded low vitamin D levels play a significant role in the 
pathogenesis of type 2 diabetes. 
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• Pittas et al (48) 
RESULTS : Insufficient vitamin D and calcium appears to hinder 
glycemic control and that supplementing both nutrients may be 
necessary to optimize glucose metabolism. 
•  Nurses Health Study (50) 
-  Observational study. 
- 83,779 women > 20 years were studied. 
 RESULTS : Found an increased risk of type 2 diabetes in those       
with low vitamin D status. A combined daily intake of > 800 IU  of 
vitamin D and 1,000 mg of calcium reduced the risk of type 2 
diabetes by 33%. 
• The National Health and Nutrition Examination Survey ( NHANES) 
III study (51) 
Study period 1988 — 1994 
RESULTS : There is a strong inverse association between low 
levels of 25(OH)D and diabetes prevalence. Low vitamin D levels  
have also been shown to be predictive of the future development of 
type 2 diabetes. 
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The following are other important studies proving the association 
of vitamin D deficiency and type 2 diabetes : 
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VITAMIN D STATUS IN INDIA: 
Despite India being a tropical country with plenty of sunshine 
vitamin D deficiency is still an epidemic in India due to several factors : 
1) Urbanisation and changes in food style contribute to low intake 
of both calcium and vitamin D. 
2) Rich fibre diet contains phosphates and phytates that impairs 
vitamin D absorption and can increase its requirement and 
deplete vit D stores (64). 
3) Heritability of vitamin D binding protein determines the 
increment in serum 25 hydroxy vit-D response to treatment(65). 
4) Genetic factors like having increased 25(OH)D-24 Hydroxylase 
enzyme which degrades 25(OH)D to inactive metabolites, also 
have a role (66).  
5) The duration of time spent indoor is increasing in urban 
population due to the rise in indoor recreation facilities which 
prevents adequate sun exposure. 
6) Air pollution due to increased automobile usage hamper the UV 
rays from reaching the skin (67). 
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7) Repeated pregnancies in dietary deficient young females 
aggravates vitamin D deficiency in both mother and baby. 
8) Traditional religious superstitions in muslim women  like 
wearing ‘pardah’ is still prevalent making them vulnerable to be 
vitamin D deficient. 
The following are suggested risk factors for people to be vit D 
deficient. 
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INDICATIONS FOR VITAMIN D TESTING: (68) 
1) Patients diagnosed with any of the vitamin D related 
diseases like rheumatoid arthritis, myocardial infarction and 
stroke especially in the young, diabetes mellitus with poor 
glycemic control, cancer, pulmonary tuberculosis especially 
drug resistant, SLE, epilepsy and others..) 
2) Patients with bone diseases like osteoporosis, 
rickets/osteomalacia. 
3) Patients with chronic nonspecific musculoskeletal pain. 
4) Signs of mental depression and asthenia 
5) Patients with gastrointestinal disease and who have had 
intestinal resection/cholecystectomy. 
6) Elderly people 
7) Obese people with BMI > 25.  
8) Exclusively breastfed infants. 
9)  Individuals taking vitamin D supplements > 50 mcg/day 
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10) Individuals who live above 42° north latitude where zenith 
angle is low. 
11) Individuals with dark complexions or who do not regularly 
receive 20 minutes of direct sunlight each day especially 
software IT professionals. 
METHODS FOR TESTING VITAMIN D: 
25(OH) vitamin D can be measured as individual components (D2, 
D3) or as a whole, but not all assays that are available have the same 
sensitivity to 25(OH) vitamin D2 and 25(OH) vitamin D3. Some 
immunoassays only detect one type of 25(OH) vitamin D and others do 
not fully detect the entire amount of each form of 25(OH) vitamin D. No 
matter what method is used, the most important value is the total serum 
25(OH) vitamin D value because it represents the total amount of vitamin 
D (both D2 and D3) that is available and circulating. It is also the same 
measure as used in the various health-based reference values. This 
ensures that the patients receive the most reliable result to determine their 
vitamin D status, regardless of level and type of supplementation (69). 
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Vitamin D deficiency can be measured (70) by using :  
1. Immuno Assay or Protein binding Assay   
 - report total vitamin D  
2. Chemical Assay- can report vitamin D2 and D3.  
Classification of vitamin D assay : 
 
  
Assay Technology Advantages Disadvantages 
Immuno Assay  RIA Specific, sensitive, 
highly 
reproducible, cost 
effective  
Manual Assay  
CLIA ECL  Sensitive,  
Auotmated  
Reagent issues,  
Problems with 
reproducibility  
Chemical 
Assay  
HPLC-UV, 
 GC-MS, 
LC-MS 
Specific, sensitive, 
highly 
reproducible  
Very costly, 
 for research 
 purposes only 
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Recommendations on vitamin D assay : 
1) Use an assay that measures both vitamin D2 and D3. Serum is 
the ideal sample type  
2) Report the total vitamin D in ng/ml. 
 Reports should include total 25 (OH) D health based reference 
values & not population based reference ranges 
 REFERENCE RANGES FOR ASSESSING VIT-D STATUS : 
Although there is no well well formed universal consensus on 
vitamin D reference values, many health care professionals believe that 
health based reference values are most preferable. Accordingly the 
following value ranges are used (71): 
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MANAGEMENT OF VITAMIN D DEFICIENCY: 
The following are the recommended dietary allowances for vitamin 
D with respect to specific age groups as put forth by the ‘Food and 
Nutrition Board’(72): 
 
Three options exist for the treatment of vitamin D deficiency: 
sunlight, artificial UVB light or vit D supplements (73). 
Sunlight : 
Adequate exposure to sunlight especially between 10 am and 3 pm 
produces vit D in the skin that last twice as long in the blood compared 
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with ingested vitamin D. If sun exposure produces slight pinkness the 
amount of vit D produced is equivalent to ingesting 10,000-25000 IU(74).   
Diet and UVB lamps: 
Since food is a poor source of vitamin D with the exception of 
coldwater ocean fish, dietary methods only supplement other treatment 
methods and cannot be used alone. Foods rich in vitamin D has been 
already mentioned previously. 
A study from Sweden comparing full body irradiation with 
artificial UVB lamps ( 3 times/week for 6 weeks) found UVB therapy 
more efficacious in rising vit D concentrations (75). 
Vitamin D supplements: 
The treatment of choice for vitamin D deficiency is Vitamin D3 
(Cholecalciferol).  Each 1000 IU of vitamin D3 in addition to a person’s 
food supply will rise the level of 25(OH)D by 10 ng/ml when it is 
constantly supplemented over a period of 3 months. Therefore, a patient 
with pretreatment  level of 10 ng / ml will usually require 3000 IU/ day 
for many months to achieve a level of 40 ng / ml and 4000 IU / day to 
achieve a level of 50 ng /ml – in the absence of UVB exposure (76).  
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The recommended doses are stated below  and it is to be noted that 
these doses are in addition to what patient is ingesting at baseline. 
Patients receiving  > 2000 IU  of vit D daily should have their serum level 
tested once in every 12 weeks. 
(77) 
 
It should also be noted that obese individuals may need higher 
doses because of the fact that vit D gets sequestered in adipose tissue. 
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Vitamin D toxicity: 
Vitamin D toxicity ( usually asymptomatic hypercalcemia) is 
exceedingly rare (78). True toxicity is secondary to the unbridled effects 
of hypercalcemia. In order to produce hypercalcemia one has to take 
more than 10,000 IU / day for many months or even years and when 
serum 25(OH)D exceeds 150 ng/ml. 
Given the multitude of actions and uniqueness of vitamin D makes 
most educated patients regulate their own tissue levels of this vitamin, 
either through UVB exposure or pharmacological supplements. Given the 
attitudes in medicine that any substance with the word ‘Vitamin’ in it 
(79), the public and not the medical profession may be the first to enter 
the vitamin D era. 
HBA1C : 
HbA1c refers to ‘glycated hemoglobin’ that identifies average 
blood glucose concentration over a period of time (2-3 months).  Glucose 
molecules in the blood normally becomes attached to haemoglobin- that 
is the haemoglobin becomes glycosylated. As a persons blood glucose 
becomes higher more of his haemoglobin becomes glycosylated. The 
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glucose remains attached to the haemoglobin for the life of the RBC’s 
which is around 2-3 months (80).  
American Diabetes Association (ADA) currently recommends an 
HbA1c of 6.5% as a cut off for diagnosing diabetes (81). 
ADA Recommendations (82): 
A1c : 
1) Do HbA1C test atleast two times a year in diabetics who 
achieve glycemic targets. 
2) Do HbA1C test quarterly in diabetics who have a recent change 
in therapy or those who do not achieve glycemic targets. 
3) Use of point of care testing for HbA1c allow for timely 
decisions on therapy changes when needed. 
Glycemic targets in adults: 
HbA1c when lowered to 7% or below decreases both 
microvascular and neuropathic complications of both types of diabetes. 
Therefore the target HbA1c goal in nonpregnant adults is in general <7%. 
The following HbA1c reference ranges depicts the appropriate 
glycemic status in diabetic patients (83). 
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Currently HbA1c values are used as, 
1) Measure of glycemic control in diabetics. 
2) Indicator of risk level for diabetic complications. 
3) Measure of quality of diabetes care. 
It is currently considered the best index for metabolic control in 
diabetes (84). 
The three main HbA1c testing methods that most clinical 
laboratories uses are (85): 
1) High pressure Liquid chromatography (HPLC) based assay 
2) Immunoassay – Based on antibody. 
3) Enzymatic assays. 
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MATERIALS AND METHODS 
Patients included in the study were recruited from the Govt. 
Mohan Kumaramangalam Medical College & Hospital.   
The study period : 
From October 2010 to September 2012. 
Type of study : Observational study. 
Inclusion criteria: 
100 diabetic patients attending diabetic op and admitted in ward 
formed the study group. 
Exclusion criteria 
1. Patients with established chronic kidney disease. 
2. Patients with established chronic liver disease. 
3. Patients on glucocorticoid therapy for any cause. 
4. Patient on antiseizure medications. 
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INVESTIGATIONS: 
 Duration of diabetes mellitus, medications patients currently on, 
other associated problems like SHT, Coronary artery heart disease, etc 
was sought from patients history. Body Mass Index ( BMI) is calculated 
using standard formula.  
-  Blood samples will be collected for total vitamin D and HbA1c 
levels estimation and was sent to thyrocare labs. Vit D levels were 
estimated using chemiluminescent immune assay (C.L.I.A). 
HbA1c value is measured using H.P.L.C using TOSOH G8. 
Correlation between Glycemic control as assessed by HbA1c value 
and vit-D levels was analysed. SSPS software was used for statistical 
analysis. 
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DURATION OF DIABETES : 
Average duration of diabetes in years were shown below. Most 
patients in the study have the disease duration less than 5 years. 
 
Duration of Diabetes In years Number Percentage % 
≤ 5 68 65.4% 
5 - 10 21 20.2% 
11 - 15 10 9.6% 
> 15 5 4.8% 
Total 104   
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VIT- D STATUS :  
The vitamin D status of the patients were assessed based on the 
health based reference values discussed previously. ( Sufficient - >30 
ng/ml, Insufficient 20-30 ng/ml, Deficient < 20 ng/ml.   
 
VITAMIN D STATUS NUMBER PERCENTAGE 
DEFICIENT 37 36.5% 
INSUFFICIENT 23 22.1% 
NORMAL 44 41.3% 
Total 104   
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HBA1C LEVELS OF PATIENTS : 
The HbA1C level of patients were rated as target range ( 6-7 %) 
high (7-8%) too high (8-9%) and very high ( > 9%). 
 
HbA1C No % 
6 - 7 Target range 6 5.8% 
7 - 8 High 29 27.9% 
8 - 9 Too High 15 14.4% 
> 9 Very High 54 51.9% 
Total 104   
 
